{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:10:33Z","timestamp":1788934233488,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In 2014, we first described novel autoantibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1-IgG\/anti-Sj) in patients with autoimmune cerebellar ataxia (ACA) in this journal. Here, we provide a review of the available literature on ITPR1-IgG\/anti-Sj, covering clinical and paraclinical presentation, tumour association, serological findings, and immunopathogenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Review of the peer-reviewed and PubMed-listed English language literature on ITPR1-IgG\/anti-Sj. In addition, we provide an illustrative report on a new patient with ITPR1-IgG-associated encephalitis with cognitive decline and psychosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>So far, at least 31 patients with serum ITPR1-IgG\/anti-Sj have been identified (clinical information available for 21). The most common manifestations were ACA, encephalopathy with seizures, myelopathy, and (radiculo)neuropathy, including autonomic neuropathy. In 45% of cases, an underlying tumour was present, making the condition a facultative paraneoplastic neurological disorder. The neurological syndrome preceded tumour diagnosis in all but one case. In most cases, immunotherapy had only moderate or no effect. The association of ITPR1-IgG\/anti-Sj with manifestations other than ACA is corroborated by the case of a 48-year-old woman with high-titre ITPR1-IgG\/anti-Sj antibodies and rapid cognitive decline, affecting memory, attention and executive function, and psychotic manifestations, including hallucinations, investigated here in detail. FDG-PET revealed right-temporal glucose hypermetabolism compatible with limbic encephalitis. Interestingly, ITPR1-IgG\/anti-Sj mainly belonged to the IgG2 subclass in both serum and cerebrospinal fluid (CSF) in this and further patients, while it was predominantly IgG1 in other patients, including those with more severe outcome, and remained detectable over the entire course of disease. Immunotherapy with intravenous methylprednisolone, plasma exchange, and intravenous immunoglobulins, was repeatedly followed by partial or complete recovery. Long-term treatment with cyclophosphamide was paralleled by relative stabilization, although the patient noted clinical worsening at the end of each treatment cycle.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The spectrum of neurological manifestations associated with ITPR1 autoimmunity is broader than initially thought. Immunotherapy may be effective in some cases. Studies evaluating the frequency of ITPR1-IgG\/anti-Sj in patients with cognitive decline and\/or psychosis of unknown aetiology are warranted. Tumour screening is essential in patients presenting with ITPR1-IgG\/anti-Sj.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12974-022-02545-4","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T08:06:51Z","timestamp":1659168411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG\/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature"],"prefix":"10.1186","volume":"19","author":[{"given":"Sven","family":"Jarius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Br\u00e4uninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha-Yeun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Geis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"2545_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-014-0206-3","volume":"11","author":"S Jarius","year":"2014","unstructured":"Jarius S, Scharf M, Begemann N, Stocker W, Probst C, Serysheva I, Nagel S, Graus F, Psimaras D, Wildemann B, Komorowski L. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia. J Neuroinflamm. 2014;11:206.","journal-title":"J Neuroinflamm"},{"key":"2545_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B. \u201cMedusa head ataxia\u201d: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflamm. 2015;12:168.","journal-title":"J Neuroinflamm"},{"key":"2545_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-015-0357-x","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B. \u201cMedusa head ataxia\u201d: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca\/ARHGAP26 and anti-VGCC. J Neuroinflamm. 2015;12:167.","journal-title":"J Neuroinflamm"},{"key":"2545_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12974-015-0356-y","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B. \u201cMedusa-head ataxia\u201d: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII. J Neuroinflamm. 2015;12:166.","journal-title":"J Neuroinflamm"},{"key":"2545_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1212\/01.wnl.0000251308.79366.f9","volume":"68","author":"L Zuliani","year":"2007","unstructured":"Zuliani L, Sabater L, Saiz A, Baiges JJ, Giometto B, Graus F. Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia. Neurology. 2007;68:239\u201340.","journal-title":"Neurology"},{"key":"2545_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/jnnp.2006.097188","volume":"77","author":"L Sabater","year":"2006","unstructured":"Sabater L, Bataller L, Carpentier AF, Aguirre-Cruz ML, Saiz A, Benyahia B, Dalmau J, Graus F. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry. 2006;77:1359\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2545_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Logmans S, Vecht C, De Zeeuw C, Sekiyama N, Nakanishi S, Shigemoto R. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.","journal-title":"N Engl J Med"},{"key":"2545_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.10451","volume":"53","author":"M Coesmans","year":"2003","unstructured":"Coesmans M, Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, van Alphen AM, Luo C, van der Geest JN, Kros JM, et al. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies. Ann Neurol. 2003;53:325\u201336.","journal-title":"Ann Neurol"},{"key":"2545_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.braindev.2006.09.004","volume":"29","author":"T Shiihara","year":"2007","unstructured":"Shiihara T, Kato M, Konno A, Takahashi Y, Hayasaka K. Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody. Brain Dev. 2007;29:254\u20136.","journal-title":"Brain Dev"},{"key":"2545_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.braindev.2006.08.011","volume":"29","author":"T Shimokaze","year":"2007","unstructured":"Shimokaze T, Kato M, Yoshimura Y, Takahashi Y, Hayasaka K. A case of acute cerebellitis accompanied by autoantibodies against glutamate receptor delta2. Brain Dev. 2007;29:224\u20136.","journal-title":"Brain Dev"},{"key":"2545_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ana.20238","volume":"56","author":"L Bataller","year":"2004","unstructured":"Bataller L, Sabater L, Saiz A, Serra C, Claramonte B, Graus F. Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2004;56:575\u20139.","journal-title":"Ann Neurol"},{"key":"2545_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/nan.12118","volume":"40","author":"R Hoftberger","year":"2014","unstructured":"Hoftberger R, Sabater L, Velasco F, Ciordia R, Dalmau J, Graus F. Carbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degeneration. Neuropathol Appl Neurobiol. 2014;40:650\u20133.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2545_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneuroim.2013.10.010","volume":"267","author":"S Doss","year":"2014","unstructured":"Doss S, N\u00fcmann A, Ziegler A, Siebert E, Borowski K, St\u00f6cker W, Pr\u00fcss H, Wildemann B, Endres M, Jarius S. Anti-Ca\/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline. J Neuroimmunol. 2014;267:102\u20134.","journal-title":"J Neuroimmunol"},{"key":"2545_CR14","first-page":"7","volume":"10","author":"S Jarius","year":"2013","unstructured":"Jarius S, Martinez-Garcia P, Hernandez AL, Brase JC, Borowski K, Regula JU, Meinck HM, Stocker W, Wildemann B, Wandinger KP. Two new cases of anti-Ca (anti-ARHGAP26\/GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflamm. 2013;10:7.","journal-title":"J Neuroinflamm"},{"key":"2545_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneuroim.2017.05.011","volume":"309","author":"U Wallwitz","year":"2017","unstructured":"Wallwitz U, Brock S, Schunck A, Wildemann B, Jarius S, Hoffmann F. From dizziness to severe ataxia and dysarthria: new cases of anti-Ca\/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum. J Neuroimmunol. 2017;309:77\u201381.","journal-title":"J Neuroimmunol"},{"key":"2545_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12974-016-0737-x","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ringelstein M, Haas J, Serysheva II, Komorowski L, Fechner K, Wandinger KP, Albrecht P, Hefter H, Moser A, et al. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy. J Neuroinflamm. 2016;13:278.","journal-title":"J Neuroinflamm"},{"key":"2545_CR17","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","volume":"4","author":"M Uhlen","year":"2005","unstructured":"Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4:1920\u201332.","journal-title":"Mol Cell Proteomics"},{"key":"2545_CR18","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1212\/NXI.0000000000000418","volume":"5","author":"N Alfugham","year":"2018","unstructured":"Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ. ITPR1 autoimmunity: frequency, neurologic phenotype, and cancer association. Neurol Neuroimmunol Neuroinflamm. 2018;5:e418.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2545_CR19","doi-asserted-by":"publisher","first-page":"27488","DOI":"10.1016\/S0021-9258(19)61534-6","volume":"275","author":"A Tanimura","year":"2000","unstructured":"Tanimura A, Tojyo Y, Turner RJ. Evidence that type I, II, and III inositol 1,4,5-trisphosphate receptors can occur as integral plasma membrane proteins. J Biol Chem. 2000;275:27488\u201393.","journal-title":"J Biol Chem"},{"key":"2545_CR20","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/S0006-3495(99)77302-9","volume":"76","author":"FW Lischka","year":"1999","unstructured":"Lischka FW, Zviman MM, Teeter JH, Restrepo D. Characterization of inositol-1,4,5-trisphosphate-gated channels in the plasma membrane of rat olfactory neurons. Biophys J. 1999;76:1410\u201322.","journal-title":"Biophys J"},{"key":"2545_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.biolcel.2003.11.004","volume":"96","author":"E Vermassen","year":"2004","unstructured":"Vermassen E, Parys JB, Mauger JP. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell. 2004;96:3\u201317.","journal-title":"Biol Cell"},{"key":"2545_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1042\/BST0340910","volume":"34","author":"CW Taylor","year":"2006","unstructured":"Taylor CW, Dellis O. Plasma membrane IP3 receptors. Biochem Soc Trans. 2006;34:910\u20132.","journal-title":"Biochem Soc Trans"},{"key":"2545_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1126\/science.1125203","volume":"313","author":"O Dellis","year":"2006","unstructured":"Dellis O, Dedos SG, Tovey SC, Taufiq Ur R, Dubel SJ, Taylor CW. Ca2+ entry through plasma membrane IP3 receptors. Science. 2006;313:229\u201333.","journal-title":"Science"},{"key":"2545_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0306-4522(93)90067-P","volume":"57","author":"AM Cunningham","year":"1993","unstructured":"Cunningham AM, Ryugo DK, Sharp AH, Reed RR, Snyder SH, Ronnett GV. Neuronal inositol 1,4,5-trisphosphate receptor localized to the plasma membrane of olfactory cilia. Neuroscience. 1993;57:339\u201352.","journal-title":"Neuroscience"},{"key":"2545_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.1323146","volume":"257","author":"AA Khan","year":"1992","unstructured":"Khan AA, Steiner JP, Klein MG, Schneider MF, Snyder SH. IP3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science. 1992;257:815\u20138.","journal-title":"Science"},{"key":"2545_CR26","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1212\/NXI.0000000000000326","volume":"4","author":"G Berzero","year":"2017","unstructured":"Berzero G, Hacohen Y, Komorowski L, Scharf M, Dehais C, Leclercq D, Fourchotte V, Buecher B, Honnorat J, Graus F, et al. Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies. Neurol Neuroimmunol Neuroinflamm. 2017;4:e326.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2545_CR27","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1212\/NXI.0000000000000306","volume":"4","author":"P Fouka","year":"2017","unstructured":"Fouka P, Alexopoulos H, Chatzi I, Dedos SG, Samiotaki M, Panayotou G, Politis P, Tzioufas A, Dalakas MC. Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease. Neurol Neuroimmunol Neuroinflamm. 2017;4:e306.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2545_CR28","doi-asserted-by":"publisher","first-page":"100104","DOI":"10.1016\/j.nerep.2022.100104","volume":"2","author":"K Lam","year":"2022","unstructured":"Lam K, Chi MS, Chan ELY, Ip WK, Chan EYT, Au EYL. Adenocarcinoma of the lung associated with antibodies to inositol 1,4,5-trisphosphate receptor 1 (ITPR1-IgG\/anti-Sj) and cerebellar ataxia. Neuroimmunol Rep. 2022;2:100104.","journal-title":"Neuroimmunol Rep"},{"key":"2545_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2020.1860965","author":"L Xu","year":"2020","unstructured":"Xu L, Xian W, Li J, Yao X, Long Y. Purkinje cell (PC) antibody positivity in a patient with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. Int J Neurosci. 2020. https:\/\/doi.org\/10.1080\/00207454.2020.1860965.","journal-title":"Int J Neurosci"},{"key":"2545_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s42466-021-00145-w","volume":"3","author":"A Cirkel","year":"2021","unstructured":"Cirkel A, Wandinger KP, Ditz C, Leppert J, Hanker L, Cirkel C, Neumann A, Brocke J, Hoftberger R, Komorowski L, et al. Paraneoplastic encephalomyeloradiculits with multiple autoantibodies against ITPR-1, GFAP and MOG: case report and literature review. Neurol Res Pract. 2021;3:48.","journal-title":"Neurol Res Pract"},{"key":"2545_CR31","doi-asserted-by":"publisher","first-page":"e244316","DOI":"10.1136\/bcr-2021-244316","volume":"14","author":"JR Schiff","year":"2021","unstructured":"Schiff JR, Fiorillo BP, Sadjadi R, Henry TL, Gruen JK, Gensler LM. Confabulation, amnesia and motor memory loss as a presentation of apparent ITPR1 antibody autoimmune encephalitis. BMJ Case Rep. 2021;14:e244316.","journal-title":"BMJ Case Rep"},{"key":"2545_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13:575\u201386.","journal-title":"Lancet Neurol"},{"key":"2545_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac090","author":"T Gruter","year":"2022","unstructured":"Gruter T, Mollers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, Kraft A, Hoftberger R, Schoberl F, et al. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain. 2022. https:\/\/doi.org\/10.1093\/brain\/awac090.","journal-title":"Brain"},{"key":"2545_CR34","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","volume":"82","author":"B Balint","year":"2014","unstructured":"Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blocker IM, Bahtz R, Komorowski L, Stocker W, Kastrup A, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology. 2014;82:1521\u20138.","journal-title":"Neurology"},{"key":"2545_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","volume":"85","author":"J Piepgras","year":"2015","unstructured":"Piepgras J, Holtje M, Michel K, Li Q, Otto C, Drenckhahn C, Probst C, Schemann M, Jarius S, Stocker W, et al. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology. 2015;85:890\u20137.","journal-title":"Neurology"},{"key":"2545_CR36","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1212\/NXI.0000000000000086","volume":"2","author":"K Stoeck","year":"2015","unstructured":"Stoeck K, Carstens PO, Jarius S, Raddatz D, Stocker W, Wildemann B, Schmidt J. Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015;2:e86.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2545_CR37","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S1474-4422(20)30341-0","volume":"19","author":"A Munoz-Lopetegi","year":"2020","unstructured":"Munoz-Lopetegi A, Graus F, Dalmau J, Santamaria J. Sleep disorders in autoimmune encephalitis. Lancet Neurol. 2020;19:1010\u201322.","journal-title":"Lancet Neurol"},{"key":"2545_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","volume":"73","author":"A Boronat","year":"2012","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N, Jeong H-Y, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, et al. Encephalitis and antibodies to DPPX, a subunit of Kv4.2 potassium channels. Ann Neurol. 2012;73:120\u20138.","journal-title":"Ann Neurol"},{"key":"2545_CR39","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.113.002764","volume":"128","author":"S Signore","year":"2013","unstructured":"Signore S, Sorrentino A, Ferreira-Martins J, Kannappan R, Shafaie M, Del Ben F, Isobe K, Arranto C, Wybieralska E, Webster A, et al. Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. Circulation. 2013;128:1286\u201397.","journal-title":"Circulation"},{"key":"2545_CR40","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"2545_CR41","doi-asserted-by":"publisher","first-page":"H2008","DOI":"10.1152\/ajpheart.00313.2006","volume":"291","author":"K Przyklenk","year":"2006","unstructured":"Przyklenk K, Maynard M, Whittaker P. First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning. Am J Physiol Heart Circ Physiol. 2006;291:H2008-2012.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2545_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/379168a0","volume":"379","author":"M Matsumoto","year":"1996","unstructured":"Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature. 1996;379:168\u201371.","journal-title":"Nature"},{"key":"2545_CR43","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Muniz-Castrillo S, Antoine JG, Desestret V, Dubey D, Giometto B, Irani SR, Joubert B, Leypoldt F, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8:e1014.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2545_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflamm. 2012;9:14.","journal-title":"J Neuroinflamm"},{"key":"2545_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hummert MW, Trebst C, Pache F, Winkelmann A, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. J Neuroinflamm. 2016;13:281.","journal-title":"J Neuroinflamm"},{"key":"2545_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12974-020-01825-1","volume":"17","author":"S Jarius","year":"2020","unstructured":"Jarius S, Lechner C, Wendel EM, Baumann M, Breu M, Schimmel M, Karenfort M, Marina AD, Merkenschlager A, Thiels C, et al. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients. J Neuroinflamm. 2020;17:262.","journal-title":"J Neuroinflamm"},{"key":"2545_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","volume":"17","author":"S Jarius","year":"2020","unstructured":"Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hummert MW, Ringelstein M, Rommer PS, Ayzenberg I, Ruprecht K, Klotz L, et al. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients. J Neuroinflamm. 2020;17:261.","journal-title":"J Neuroinflamm"},{"key":"2545_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflamm. 2016;13:280.","journal-title":"J Neuroinflamm"},{"key":"2545_CR49","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflamm. 2016;13:279.","journal-title":"J Neuroinflamm"},{"key":"2545_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011;306:82\u201390.","journal-title":"J Neurol Sci"},{"key":"2545_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","volume":"6","author":"S Jarius","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers. 2020;6:85.","journal-title":"Nat Rev Dis Primers"},{"key":"2545_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/B978-0-12-800100-4.00006-4","volume":"121","author":"M Levy","year":"2014","unstructured":"Levy M, Wildemann B, Jarius S, Orellano B, Sasidharan S, Weber MS, Stuve O. Immunopathogenesis of neuromyelitis optica. Adv Immunol. 2014;121:213\u201342.","journal-title":"Adv Immunol"},{"key":"2545_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008;4:202\u201314.","journal-title":"Nat Clin Pract Neurol"},{"key":"2545_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010;6:383\u201392.","journal-title":"Nat Rev Neurol"},{"key":"2545_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-3083.1989.tb01225.x","volume":"30","author":"P Garred","year":"1989","unstructured":"Garred P, Michaelsen TE, Aase A. The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration. Scand J Immunol. 1989;30:379\u201382.","journal-title":"Scand J Immunol"},{"key":"2545_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.1991.tb08115.x","volume":"84","author":"YM Lucisano Valim","year":"1991","unstructured":"Lucisano Valim YM, Lachmann PJ. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol. 1991;84:1\u20138.","journal-title":"Clin Exp Immunol"},{"key":"2545_CR57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/1535-7163.MCT-18-0341","volume":"18","author":"T Rosner","year":"2019","unstructured":"Rosner T, Kahle S, Montenegro F, Matlung HL, Jansen JHM, Evers M, Beurskens F, Leusen JHW, van den Berg TK, Valerius T. Immune effector functions of human IgG2 antibodies against EGFR. Mol Cancer Ther. 2019;18:75\u201388.","journal-title":"Mol Cancer Ther"},{"key":"2545_CR58","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.","journal-title":"Front Immunol"},{"key":"2545_CR59","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.1248943","volume":"343","author":"CA Diebolder","year":"2014","unstructured":"Diebolder CA, Beurskens FJ, de Jong RN, Koning RI, Strumane K, Lindorfer MA, Voorhorst M, Ugurlar D, Rosati S, Heck AJ, et al. Complement is activated by IgG hexamers assembled at the cell surface. Science. 2014;343:1260\u20133.","journal-title":"Science"},{"key":"2545_CR60","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daeron M. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113:3716\u201325.","journal-title":"Blood"},{"key":"2545_CR61","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.166.5.1351","volume":"166","author":"M Bruggemann","year":"1987","unstructured":"Bruggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger MS. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med. 1987;166:1351\u201361.","journal-title":"J Exp Med"},{"key":"2545_CR62","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4049\/jimmunol.0900847","volume":"184","author":"T Schneider-Merck","year":"2010","unstructured":"Schneider-Merck T, Lammerts van Bueren JJ, Berger S, Rossen K, van Berkel PH, Derer S, Beyer T, Lohse S, Bleeker WK, Peipp M, et al. Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage. J Immunol. 2010;184:512\u201320.","journal-title":"J Immunol"},{"key":"2545_CR63","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00309627","volume":"89","author":"JE Greenlee","year":"1995","unstructured":"Greenlee JE, Burns JB, Rose JW, Jaeckle KA, Clawson S. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol. 1995;89:341\u20135.","journal-title":"Acta Neuropathol"},{"key":"2545_CR64","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/NEN.0b013e3181f0c82b","volume":"69","author":"JE Greenlee","year":"2010","unstructured":"Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol. 2010;69:997\u20131007.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2545_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-2094-6-31","volume":"6","author":"KE Hill","year":"2009","unstructured":"Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE. Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflamm. 2009;6:31.","journal-title":"J Neuroinflamm"},{"key":"2545_CR66","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1212\/WNL.37.11.1780","volume":"37","author":"RH Fabian","year":"1987","unstructured":"Fabian RH, Petroff G. Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport. Neurology. 1987;37:1780\u20134.","journal-title":"Neurology"},{"key":"2545_CR67","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0022-510X(86)90150-4","volume":"73","author":"RH Fabian","year":"1986","unstructured":"Fabian RH, Ritchie TC. Intraneuronal IgG in the central nervous system. J Neurol Sci. 1986;73:257\u201367.","journal-title":"J Neurol Sci"},{"key":"2545_CR68","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1001\/archneur.1985.04060070084021","volume":"42","author":"LF Borges","year":"1985","unstructured":"Borges LF, Busis NA. Intraneuronal accumulation of myeloma proteins. Arch Neurol. 1985;42:690\u20134.","journal-title":"Arch Neurol"},{"key":"2545_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0022-510X(91)90198-G","volume":"106","author":"F Graus","year":"1991","unstructured":"Graus F, Illa I, Agusti M, Ribalta T, Cruz-Sanchez F, Juarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci. 1991;106:82\u20137.","journal-title":"J Neurol Sci"},{"key":"2545_CR70","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneuroim.2013.05.003","volume":"261","author":"E Martin-Garcia","year":"2013","unstructured":"Martin-Garcia E, Mannara F, Gutierrez-Cuesta J, Sabater L, Dalmau J, Maldonado R, Graus F. Intrathecal injection of P\/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. J Neuroimmunol. 2013;261:53\u20139.","journal-title":"J Neuroimmunol"},{"key":"2545_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0303-8467(95)00006-6","volume":"97","author":"K Tanaka","year":"1995","unstructured":"Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg. 1995;97:101\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"2545_CR72","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00401-014-1351-6","volume":"128","author":"M Schubert","year":"2014","unstructured":"Schubert M, Panja D, Haugen M, Bramham CR, Vedeler CA. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathol. 2014;128:835\u201352.","journal-title":"Acta Neuropathol"},{"key":"2545_CR73","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0165-5728(95)00063-8","volume":"60","author":"K Sakai","year":"1995","unstructured":"Sakai K, Gofuku M, Kitagawa Y, Ogasawara T, Hirose G. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. J Neuroimmunol. 1995;60:135\u201341.","journal-title":"J Neuroimmunol"},{"key":"2545_CR74","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1093\/brain\/awq253","volume":"133","author":"C Geis","year":"2010","unstructured":"Geis C, Weishaupt A, Hallermann S, Grunewald B, Wessig C, Wultsch T, Reif A, Byts N, Beck M, Jablonka S, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain. 2010;133:3166\u201380.","journal-title":"Brain"},{"key":"2545_CR75","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(05)66376-3","volume":"365","author":"C Sommer","year":"2005","unstructured":"Sommer C, Weishaupt A, Brinkhoff J, Biko L, Wessig C, Gold R, Toyka KV. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet. 2005;365:1406\u201311.","journal-title":"Lancet"},{"key":"2545_CR76","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1093\/brain\/awq302","volume":"133","author":"A Vincent","year":"2010","unstructured":"Vincent A. Successful \u201cpassive transfer\u201d of paraneoplastic stiff person syndrome with antibodies to an intracellular antigen. Brain. 2010;133:3164\u20135.","journal-title":"Brain"},{"key":"2545_CR77","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00702-012-0773-3","volume":"119","author":"C Geis","year":"2012","unstructured":"Geis C, Grunewald B, Weishaupt A, Wultsch T, Toyka KV, Reif A, Sommer C. Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. J Neural Transm. 2012;119:981\u20135.","journal-title":"J Neural Transm"},{"key":"2545_CR78","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0165-5728(02)00314-4","volume":"132","author":"S Shiraga","year":"2002","unstructured":"Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol. 2002;132:72\u201382.","journal-title":"J Neuroimmunol"},{"key":"2545_CR79","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2012.10.013","volume":"239","author":"N Hansen","year":"2013","unstructured":"Hansen N, Grunewald B, Weishaupt A, Colaco MN, Toyka KV, Sommer C, Geis C. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol. 2013;239:202\u20139.","journal-title":"Exp Neurol"},{"key":"2545_CR80","doi-asserted-by":"publisher","first-page":"e16775","DOI":"10.1371\/journal.pone.0016775","volume":"6","author":"C Geis","year":"2011","unstructured":"Geis C, Weishaupt A, Grunewald B, Wultsch T, Reif A, Gerlach M, Dirkx R, Solimena M, Perani D, Heckmann M, et al. Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS ONE. 2011;6:e16775.","journal-title":"PLoS ONE"},{"key":"2545_CR81","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/1523-1747.ep12469994","volume":"100","author":"TD Golan","year":"1993","unstructured":"Golan TD, Gharavi AE, Elkon KB. Penetration of autoantibodies into living epithelial cells. J Invest Dermatol. 1993;100:316\u201322.","journal-title":"J Invest Dermatol"},{"key":"2545_CR82","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4049\/jimmunol.157.5.2082","volume":"157","author":"DJ Zack","year":"1996","unstructured":"Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J Immunol. 1996;157:2082\u20138.","journal-title":"J Immunol"},{"key":"2545_CR83","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI119517","volume":"100","author":"K Yanase","year":"1997","unstructured":"Yanase K, Smith RM, Puccetti A, Jarett L, Madaio MP. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest. 1997;100:25\u201331.","journal-title":"J Clin Invest"},{"key":"2545_CR84","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1212\/WNL.38.7.1018","volume":"38","author":"NE Anderson","year":"1988","unstructured":"Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Rosenblum MK, Nadeau SE, Posner JB. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Neurology. 1988;38:1018\u201326.","journal-title":"Neurology"},{"key":"2545_CR85","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrm1150","volume":"4","author":"S Orrenius","year":"2003","unstructured":"Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4:552\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2545_CR86","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/ncb1063","volume":"5","author":"D Boehning","year":"2003","unstructured":"Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol. 2003;5:1051\u201361.","journal-title":"Nat Cell Biol"},{"key":"2545_CR87","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4161\/cc.3.3.705","volume":"3","author":"D Boehning","year":"2004","unstructured":"Boehning D, Patterson RL, Snyder SH. Apoptosis and calcium: new roles for cytochrome c and inositol 1,4,5-trisphosphate. Cell Cycle. 2004;3:252\u20134.","journal-title":"Cell Cycle"},{"key":"2545_CR88","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/gps.1042","volume":"19","author":"E Kalbe","year":"2004","unstructured":"Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, Bullock R. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 2004;19:136\u201343.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2545_CR89","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jneuroim.2008.06.004","volume":"200","author":"D Franciotta","year":"2008","unstructured":"Franciotta D, Columba-Cabezas S, Andreoni L, Ravaglia S, Jarius S, Romagnolo S, Tavazzi E, Bergamaschi R, Zardini E, Aloisi F, Marchioni E. Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases. J Neuroimmunol. 2008;200:125\u20138.","journal-title":"J Neuroimmunol"},{"key":"2545_CR90","first-page":"99","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H. Cerebrospinal fluid\u2014physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998;4:99\u2013107.","journal-title":"Mult Scler"},{"key":"2545_CR91","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.12.006","volume":"256","author":"S Jarius","year":"2013","unstructured":"Jarius S, Steinmeyer F, Knobel A, Streitberger K, Hotter B, Horn S, Heuer H, Schreiber SJ, Wilhelm T, Trefzer U, et al. GABAB receptor antibodies in paraneoplastic cerebellar ataxia. J Neuroimmunol. 2013;256:94\u20136.","journal-title":"J Neuroimmunol"},{"key":"2545_CR92","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jneuroim.2013.04.004","volume":"259","author":"S Mundiyanapurath","year":"2013","unstructured":"Mundiyanapurath S, Jarius S, Probst C, Stocker W, Wildemann B, Bosel J. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. J Neuroimmunol. 2013;259:88\u201391.","journal-title":"J Neuroimmunol"},{"key":"2545_CR93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-017-0900-z","volume":"14","author":"S Hahn","year":"2017","unstructured":"Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, Probst C, Wandinger KP, Buttmann M, Haarmann A, et al. Identification of the flotillin-1\/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. J Neuroinflammation. 2017;14:123.","journal-title":"J Neuroinflammation"},{"key":"2545_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Logmans S, Vecht C, De Zeeuw C, Sekiyama N, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.","journal-title":"N Engl J Med."}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02545-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T01:42:32Z","timestamp":1676252552000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02545-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02545-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written informed consent for publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.J., S.B., H.Y.C., C.G., J.H., B.W. and C.R. report no conflicts of interest. L.K. is an employee of Euroimmun AG, L\u00fcbeck, Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}